SPRINGWORKS THERAPEUTICS, INC. Share-based Payment Arrangement, Expense
SPRINGWORKS THERAPEUTICS, INC. reported Share-based Payment Arrangement, Expense of $29.95 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-05-09
- SPRINGWORKS THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $29.95M, a 1.69% decline year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2024-12-31 was $26.47M, a 5.60% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $25.96M, a 12.40% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $26.25M, a 14.24% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2024 was $109.14M, a 15.45% increase from fiscal 2023.
- SPRINGWORKS THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2023 was $94.53M, a 29.56% increase from fiscal 2022.
- SPRINGWORKS THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2022 was $72.97M, a 89.80% increase from fiscal 2021.
- SPRINGWORKS THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2021 was $38.44M, a 283.14% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $29.95M 10-Q · filed 2025-05-09 | $56.42M derived: sum of 2 quarters · filed 2025-05-09 | $82.38M derived: sum of 3 quarters · filed 2025-05-09 | $108.63M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | $26.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $52.43M derived: sum of 2 quarters · filed 2025-02-20 | $78.68M derived: sum of 3 quarters · filed 2025-02-20 | $109.14M 10-K · filed 2025-02-20 |
| 2024-09-30 | $25.96M 10-Q · filed 2024-11-12 | $52.21M derived: sum of 2 quarters · filed 2024-11-12 | $82.67M 10-Q · filed 2024-11-12 | $107.74M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-06-30 | $26.25M 10-Q · filed 2024-08-07 | $56.71M 10-Q · filed 2024-08-07 | $81.77M derived: sum of 3 quarters · filed 2025-05-09 | $104.87M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-03-31 | $30.46M 10-Q · filed 2025-05-09 | $55.53M derived: sum of 2 quarters · filed 2025-05-09 | $78.63M derived: sum of 3 quarters · filed 2025-05-09 | $101.60M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $25.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $48.17M derived: sum of 2 quarters · filed 2025-02-20 | $71.14M derived: sum of 3 quarters · filed 2025-02-20 | $94.53M 10-K · filed 2025-02-20 |
| 2023-09-30 | $23.10M 10-Q · filed 2024-11-12 | $46.07M derived: sum of 2 quarters · filed 2024-11-12 | $69.47M 10-Q · filed 2024-11-12 | $88.39M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $22.97M 10-Q · filed 2024-08-07 | $46.37M 10-Q · filed 2024-08-07 | $65.29M derived: sum of 3 quarters · filed 2025-02-20 | $83.81M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $23.39M 10-Q · filed 2024-05-02 | $42.32M derived: sum of 2 quarters · filed 2025-02-20 | $60.84M derived: sum of 3 quarters · filed 2025-02-20 | $79.27M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $18.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $37.44M derived: sum of 2 quarters · filed 2025-02-20 | $55.87M derived: sum of 3 quarters · filed 2025-02-20 | $72.97M 10-K · filed 2025-02-20 |
| 2022-09-30 | $18.52M 10-Q · filed 2023-11-02 | $36.95M derived: sum of 2 quarters · filed 2023-11-02 | $54.04M 10-Q · filed 2023-11-02 | $65.92M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $18.43M 10-Q · filed 2023-08-02 | $35.52M 10-Q · filed 2023-08-02 | $47.41M derived: sum of 3 quarters · filed 2024-02-27 | $58.12M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $17.09M 10-Q · filed 2023-05-03 | $28.98M derived: sum of 2 quarters · filed 2024-02-27 | $39.69M derived: sum of 3 quarters · filed 2024-02-27 | $48.48M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $11.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $22.59M derived: sum of 2 quarters · filed 2024-02-27 | $31.39M derived: sum of 3 quarters · filed 2024-02-27 | $38.44M 10-K · filed 2024-02-27 |
| 2021-09-30 | $10.71M 10-Q · filed 2022-11-03 | $19.51M derived: sum of 2 quarters · filed 2022-11-03 | $26.56M 10-Q · filed 2022-11-03 | $29.60M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $8.79M 10-Q · filed 2022-08-04 | $15.85M 10-Q · filed 2022-08-04 | $18.89M derived: sum of 3 quarters · filed 2023-02-28 | $21.93M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $7.05M 10-Q · filed 2022-05-05 | $10.10M derived: sum of 2 quarters · filed 2023-02-28 | $13.14M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | $3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $6.08M derived: sum of 2 quarters · filed 2023-02-28 | $10.03M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $3.04M 10-Q · filed 2021-11-04 | $6.99M 10-Q · filed 2021-11-04 | ||
| 2019-12-31 | $950.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.74M derived: sum of 2 quarters · filed 2022-02-24 | $3.11M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $788.00K 10-Q · filed 2019-11-12 | $2.16M 10-Q · filed 2019-11-12 | ||
| 2018-12-31 | $226.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $461.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.07M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $235.00K 10-Q · filed 2019-11-12 | $843.00K 10-Q · filed 2019-11-12 |